Product Information
ROPINIROLE HCL 3 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0806 per EA under NDC 62332003431. Its NADAC has been published 537 times since May 11, 2016.
FDA first approved this application on Mar 24, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332003431
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090429FDA Approved
3/24/2010
TE Code
AB
On Market Since
1/29/2016
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 3 MG TABLET has been published 537 times since May 11, 2016, and over the history we have for it it has declined 25.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0806 per EA |
|---|---|
| All-time high | $0.1353 (Feb 15, 2017) |
| All-time low | $0.0575 (Nov 20, 2024) |
| 52-week high | $0.0848 |
| 52-week low | $0.0795 |
| Median price | $0.0863 |
| Average price | $0.0930 |
| Largest weekly change | +39.8% (Dec 19, 2018) |
| Weeks tracked | 537 |
| Tracking since | May 11, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ROPINIROLE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 3 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0806 per EA (NDC 62332003431), effective Aug 19, 2026.
How has the price of ROPINIROLE HCL 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 3 MG TABLET has declined 25.9%. It has been tracked across 537 weekly CMS publications since May 11, 2016.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 3 MG TABLET?
Since May 11, 2016, the NADAC for ROPINIROLE HCL 3 MG TABLET has ranged from a low of $0.0575 (Nov 20, 2024) to a high of $0.1353 (Feb 15, 2017), with a median of $0.0863 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 3 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ROPINIROLE HCL 3 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ROPINIROLE HCL 3 MG TABLET?
ROPINIROLE HCL 3 MG TABLET (NDC 62332003431) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.